LogicFlo AI Raises $2.7M Seed Round to Accelerate Global Expansion in Life Sciences

LogicFlo AI an artificial intelligence platform tailored for the life sciences sector, has raised $2.7 million in a seed funding round led by Lightspeed, with participation from healthcare-focused and enterprise AI investors. The capital will be used to support global expansion across pharmaceutical, biotech, and medtech companies, and to deepen its deployments with existing clients—including a Fortune 500 company already on board.

Founded by Udith Vaidyanathan and Arun Ramakrishnan, LogicFlo AI is transforming the way regulated scientific work is conducted. By replacing outdated, fragmented tools and repetitive processes with intelligent AI agents, the platform significantly boosts productivity in regulatory affairs, medical writing, quality assurance, and medical information workflows.

Already operational within several global life sciences firms, LogicFlo AI has delivered impressive early results—cutting medical writing timelines from weeks to minutes and reducing medical information response times from nearly two weeks to just two days.

With the fresh funding, the company aims to accelerate product development, scale its technical and go-to-market teams, and deepen integrations with key life sciences platforms like Veeva and IQVIA.

“We are at a once-in-a-generation inflection point,” said Udith Vaidyanathan, Co-founder and CEO. “Our AI agents are designed to enhance—not replace—human expertise. We're focused on empowering professionals to elevate the standard of care through intelligent, high-compliance automation.”

Arun Ramakrishnan, Co-founder and CTO, added, “Unlike traditional automation tools that are rigid and disconnected from real workflows, LogicFlo AI agents are intelligent, composable, and attuned to the nuanced demands of scientific work.”

Rohil Bagga, VP of Investments at Lightspeed, praised the founding team’s domain knowledge and technical capabilities, stating:

“LogicFlo AI is revolutionizing how life sciences organizations operate. Their AI agent platform dramatically enhances productivity for medical and commercial teams—this is the future of intelligent workflows in healthcare.”

With AI poised to reshape highly regulated sectors, LogicFlo AI is positioning itself as a key enabler in the next evolution of life sciences innovation.